- Home
- ZUMZ vs CMPS Comparison
ZUMZ vs CMPS Comparison
Compare ZUMZ & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZUMZ
- CMPS
- Stock Information
- Founded
- ZUMZ 1978
- CMPS 2020
- Country
- ZUMZ United States
- CMPS United Kingdom
- Employees
- ZUMZ N/A
- CMPS N/A
- Industry
- ZUMZ Clothing/Shoe/Accessory Stores
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- ZUMZ Consumer Discretionary
- CMPS Health Care
- Exchange
- ZUMZ Nasdaq
- CMPS Nasdaq
- Market Cap
- ZUMZ 247.5M
- CMPS 364.9M
- IPO Year
- ZUMZ 2005
- CMPS 2020
- Fundamental
- Price
- ZUMZ $12.49
- CMPS $4.16
- Analyst Decision
- ZUMZ Hold
- CMPS Strong Buy
- Analyst Count
- ZUMZ 2
- CMPS 7
- Target Price
- ZUMZ $22.00
- CMPS $18.83
- AVG Volume (30 Days)
- ZUMZ 220.1K
- CMPS 1.0M
- Earning Date
- ZUMZ 06-05-2025
- CMPS 05-08-2025
- Dividend Yield
- ZUMZ N/A
- CMPS N/A
- EPS Growth
- ZUMZ N/A
- CMPS N/A
- EPS
- ZUMZ N/A
- CMPS N/A
- Revenue
- ZUMZ $889,202,000.00
- CMPS N/A
- Revenue This Year
- ZUMZ $3.19
- CMPS N/A
- Revenue Next Year
- ZUMZ $1.71
- CMPS N/A
- P/E Ratio
- ZUMZ N/A
- CMPS N/A
- Revenue Growth
- ZUMZ 1.57
- CMPS N/A
- 52 Week Low
- ZUMZ $11.31
- CMPS $2.49
- 52 Week High
- ZUMZ $31.37
- CMPS $8.54
- Technical
- Relative Strength Index (RSI)
- ZUMZ 47.58
- CMPS 55.37
- Support Level
- ZUMZ $11.66
- CMPS $3.86
- Resistance Level
- ZUMZ $13.31
- CMPS $4.52
- Average True Range (ATR)
- ZUMZ 0.50
- CMPS 0.32
- MACD
- ZUMZ 0.03
- CMPS -0.02
- Stochastic Oscillator
- ZUMZ 40.89
- CMPS 32.03
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.